# Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)

> **NCT05839717** · — · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 120 (estimated)

## Conditions studied

- Myeloproliferative Neoplasm

## Interventions

- **PROCEDURE:** Blood sampling

## Key facts

- **NCT ID:** NCT05839717
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-19
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05839717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05839717, "Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05839717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*